What are the side effects of acotinib/cancostat and how to deal with them?

Acalabrutinib (Acalabrutinib) is a Bruton's tyrosine kinase (BTK) inhibitor with broad anti-cancer effects and is especially suitable for the treatment of B-cell malignancies (non-Hodgkin's lymphoma). However, like all medications, acotinib may cause some side effects. Here are common side effects and how to deal with them:

1. Hematological side effects: acotinib may cause thrombocytopenia, anemia, leukopenia, etc. Patients may experience symptoms of fatigue, bleeding or infection easily. To prevent serious complications, regular blood tests are recommended. If significant symptoms of low blood cells occur, the drug dose may need to be adjusted or treatment suspended.

2. Blood system reaction: acotinib may cause thrombocytopenia, anemia or leukopenia, and patients may experience symptoms such as fatigue and bleeding tendency. For these symptoms, it is recommended to regularly monitor blood routine and adjust the drug dosage or carry out symptomatic treatment under the guidance of a doctor.

3. Cardiovascular problems: Some patients may develop arrhythmia, such as atrial fibrillation, especially elderly patients. If patients develop uncomfortable symptoms such as palpitations and chest pain, they should seek medical treatment promptly, and treatment may need to be suspended or medications adjusted.

4. Gastrointestinal reactions: Gastrointestinal discomforts such as nausea, vomiting, and loss of appetite are also common side effects. For this type of reaction, patients can take medication after meals, or consider using anti-nausea medications for symptomatic management.

5. Increased risk of infection: As an immunosuppressive drug, acotinib may increase the risk of infection. Patients should take care to avoid contact with infected people and promptly treat any symptoms of infection.

For these side effects, patients need to keep close contact with their doctors and promptly stop taking the medication or adjust the treatment plan when serious side effects occur. During the treatment of acotinib, regular examination and monitoring are crucial, which can help doctors adjust treatment in a timely manner and reduce the impact of side effects on patients.

Reference materials:https://www.calquence.com/